Skip to main content
. 2007 Jan 29;104(6):1943–1946. doi: 10.1073/pnas.0610860104

Fig. 2.

Fig. 2.

Effect of treatment with GHRH antagonist JMR-132 given s.c. at a dose of 10 μg/day (column 3), docetaxel given i.p. at a concentration of 20 milligrams per kilogram of body weight on days 1 and 5 (column 2), or the combination of JMR-132 with docetaxel (column 4) on the tumor weight of MX-1 human breast cancer xenografted s.c. into nude mice. Vertical bars indicate SE. *, P < 0.001 vs. control; **, P < 0.001 vs. control (column 1) and the groups receiving single agents.